Alerts

Read about the supply of Ordine (morphine) oral liquid being discontinued in Australia between November 2023 and early 2024.

We have been notified that the shortage of tenecteplase (Metalyse) will continue until 31 December 2024.

The TGA has received reports of liver problems experienced by consumers taking medicines containing turmeric or curcumin.

The TGA is aware of a shortage of all hydrocortisone tablet strengths due to manufacturing issues. We are working with the supplier Alphapharm Pty Ltd to manage the impact.

Novo Nordisk Pharmaceuticals has notified the TGA about a critical shortage of the emergency glucagon product GlucaGen HypoKit.

Read about how the shortage of oral cefalexin medicines, that started in December 2022, no longer applies to capsules.

Novo Nordisk Pharmaceuticals has notified the TGA about a shortage of the somatropin products Norditropin FlexPro.

Users may experience extended periods of signal loss and during this time they won’t receive high or low glucose alarms.

Mentholatum Australasia Pty Ltd is recalling two batches of Natural Instinct Kids SPF50+ Clean Sunscreen 200mL topical cream and 50mL rollerball products after receiving reports that the sunscreen fluid is splitting into layers.

We have been notified of a current shortage of Ryzodeg 70/30 FlexTouch insulin prefilled pen, until 5 June 2024.

Find out what the discontinuation of Ordine (morphine) oral liquid means for you.

The supply of Ozempic (semaglutide) in Australia is improving however the shortage continues. Stay updated about how the shortage impacts you.

Australia tablets pose a serious risk to your health and should not be taken.

Big Penis USA tablets pose a serious risk to your health and should not be taken.

Germany Niubian tablets pose a serious risk to your health and should not be taken.

The TGA has recently tested the contents of Kamini, and found ingredients in Kamini that pose a serious risk if ingested.

USA Black Gold tablets pose a serious risk to your health and should not be taken.

We have updated the information about these shortages with new details about affected products and a link to an additional resource for health professionals.

A warning about serious kidney damage has been added to the prescribing information for all oral anticoagulants in Australia.

The TGA is warning consumers against taking EVE branded products that contain allylisopropylacetylurea (apronal) as they pose a significant health risk and are prohibited from sale, supply or use in Australia.

The TGA has detected fake semaglutide, also known as Ozempic, being illegally imported into Australia.

Information about the shortage of some antibiotics, including amoxicillin and metronidazole medicines

A safety warning has been added to a class of medicines called Janus Kinase inhibitors used for chronic inflammatory conditions.

We continue to monitor antibiotic medicines in shortage and are seeking and prioritising applications for overseas alternatives to assist with supply.

There remains an increased global demand for semaglutide products which is impacting availability and certainty of supply of Ozempic (semaglutide) in Australia until early 2023.